CD4+CD25high Regulatory T Cells Are Markedly Decreased in Blood of Patients with Pemphigus Vulgaris

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Dermatology

• Publication date

  2007-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000099585PMID 17377382
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CD 4 + CD 25 high regulatory T cells and CD 4 + CD 69 + T cells in peripheral blood of patients with cutaneous lupus erythematosus

  2009cited by this paper
• CD4+/CD25+ T-regulatory cells

  2008cited by this paper
• The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age

  2005cited by this paper
• Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide.

  2005cited by this paper
• Dysfunctional Blood and Target Tissue CD4+CD25high Regulatory T Cells in Psoriasis: Mechanism Underlying Unrestrained Pathogenic Effector T Cell Proliferation1

  2005cited by this paper
• Determining suitable internal standards for mRNA quantification of increasing cancer progression in human breast cells by real-time reverse transcriptase polymerase chain reaction.

  2005cited by this paper
• CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome.

  2005cited by this paper
• Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.

  2005cited by this paper
• Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis.

  2005cited by this paper
• Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells

  2005cited by this paper
• Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.

  2005cited by this paper
• Inhibitory and Stimulatory Effects of Cyclosporine A on the Development of Regulatory T Cells In Vivo

  2005cited by this paper
• Regulatory T cells and mechanisms of immune system control

  2004cited by this paper
• Desmosomes and disease: pemphigus and bullous impetigo.

  2004cited by this paper
• Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma.

  2004cited by this paper
• Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis

  2004cited by this paper
• Type I Regulatory T Cells Specific for Desmoglein 3 Are More Frequently Detected in Healthy Individuals than in Patients with Pemphigus Vulgaris1

  2004cited by this paper
• Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.

  2004cited by this paper
• Differential response of murine CD4+CD25+ and CD4+CD25– T cells to dexamethasone‐induced cell death

  2004cited by this paper
• Defective Suppressor Function of Human CD4+ CD25+ Regulatory T Cells in Autoimmune Polyglandular Syndrome Type II

  2004cited by this paper
• Decreased CD4+CD25+ T Cells in Peripheral Blood of Patients with Systemic Lupus Erythematosus

  2004cited by this paper
• Suppressor T Cells in Human Diseases

  2004cited by this paper
• Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy

  2004cited by this paper
• Antigen-induced regulatory T cells.

  2004cited by this paper
• Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease.

  2004cited by this paper
• Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells.

  2004cited by this paper
• Regulatory T cells: friend or foe in immunity to infection?

  2004cited by this paper
• Foxp 3 programs the development and function of CD 4 + CD 25 + regulatory T cells

  2003cited by this paper
• Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

  2003cited by this paper
• Quantification of regulatory T cells in patients with systemic lupus erythematosus.

  2003cited by this paper
• Dichotomy of Autoreactive Th1 and Th2 Cell Responses to Desmoglein 3 in Patients with Pemphigus Vulgaris (PV) and Healthy Carriers of PV-Associated HLA Class II Alleles1

  2003cited by this paper
• An essential role for Scurfin in CD4+CD25+ T regulatory cells

  2003cited by this paper
• CD4+CD25+ regulatory cells from human peripheral blood express very high levels of CD25 ex vivo.

  2003cited by this paper
• A Comparative Study between T Regulatory Type 1 and CD4+CD25+ T Cells in the Control of Inflammation 1

  2003cited by this paper
• Cutting Edge: Cure of Colitis by CD4+CD25+ Regulatory T Cells1

  2003cited by this paper
• A Comparative Study between T Regulatory Type 1 and CD4 CD25 T Cells in the Control of Inflammation

  2003cited by this paper
• Supporting Online Material

  2002cited by this paper
• Cutting Edge: Depletion of CD4+CD25+ Regulatory T Cells Is Necessary, But Not Sufficient, for Induction of Organ-Specific Autoimmune Disease

  2002cited by this paper
• Infectious Tolerance

  2002cited by this paper
• CD4+CD25+ suppressor T cells: more questions than answers

  2002cited by this paper
• Human CD4+CD25+ Regulatory, Contact-dependent T Cells Induce Interleukin 10–producing, Contact-independent Type 1-like Regulatory T Cells

  2002cited by this paper
• Regulatory T Cells Induced by 1α,25-Dihydroxyvitamin D3 and Mycophenolate Mofetil Treatment Mediate Transplantation Tolerance1

  2001cited by this paper
• Unique Chemotactic Response Profile and Specific Expression of Chemokine Receptors Ccr4 and Ccr8 by Cd4+Cd25+ Regulatory T Cells

  2001cited by this paper
• CD4+CD25high Regulatory Cells in Human Peripheral Blood1

  2001cited by this paper
• Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human Blood

  2001cited by this paper
• Regulatory T Cells Induced by 1 ,25-Dihydroxyvitamin D3 and Mycophenolate Mofetil Treatment Mediate Transplantation Tolerance

  2001cited by this paper
• Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activity in vitro

  2001cited by this paper
• X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy

  2001cited by this paper
• Regulatory T cells in the control of immune pathology

  2001cited by this paper
• Human Cd25+Cd4+ T Regulatory Cells Suppress Naive and Memory T Cell Proliferation and Can Be Expanded in Vitro without Loss of Function

  2001cited by this paper
• JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome.

  2000cited by this paper
• Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus.

  2000cited by this paper
• B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.

  2000cited by this paper
• Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.

  1998cited by this paper
• Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation

  1996cited by this paper
• ASSOCIATIONS OF PEMPHIGUS AND AUTOIMMUNE DISEASE WITH MALIGNANCY OR THYMOMA

  1994cited by this paper
• Organ-specific autoimmune disease induced in mice by elimination of T cell subsets. V. Neonatal administration of cyclosporin A causes autoimmune disease.

  1989cited by this paper
• In vivo studies of antibody dependent acantholysis.

  1989cited by this paper

• Autoimmune Bullous Diseases: Therapeutic Update.

  2026cites this paper
• Healthy individuals genetically at-risk for the development of Pemphigus vulgaris or Alopecia areata share disease-like cytokine dysregulation

  2025cites this paper
• Updates in Pathogenesis of Pemphigus Vulgaris.

  2025cites this paper
• FOXP3 gene variant rs3761548 in pemphigus vulgaris and bullous pemphigoid

  2025cites this paper
• Can we cure bullous skin diseases?

  2025cites this paper
• JAK-STAT pathway, type I/II cytokines, and new potential therapeutic strategy for autoimmune bullous diseases: update on pemphigus vulgaris and bullous pemphigoid

  2025cites this paper
• Mechanisms of Resistance to Rituximab Used for the Treatment of Autoimmune Blistering Diseases

  2024cites this paper
• Cytokine profiling reveals HLA-linked Th2 and Th17 driven immune activation in pemphigus vulgaris patients and genetically susceptible healthy controls

  2024cites this paper
• Immune interplay from circulation to local lesion in pemphigus pathogenesis.

  2024cites this paper
• Type 2 T cell responses against distinct epitopes of the desmoglein 3 ectodomain in pemphigus vulgaris.

  2023cites this paper
• Organochlorine pesticides disrupt T helper cell regulation and reduce IL-2 and IFN-γ favoring infection and production of autoantibodies among pemphigus patients.

  2023cites this paper
• Single-Cell Transcriptomes and Immune Repertoires Reveal the Cell State and Molecular Changes in Pemphigus Vulgaris

  2023cites this paper
• Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders – Advances and challenges

  2022cites this paper
• The emerging role of T cells in pemphigus vulgaris: a systematic review

  2022influential citation
• A potential reciprocal emergence of regulatory T cells in oral lichen planus and pemphigus vulgaris: A meta-analysis

  2022cites this paper
• Immunohistochemical expression of regulatory T cells (CD4+ CD25+ bright FOXP3+) in pemphigus patients

  2022cites this paper
• Autoreactive T cells in pemphigus: perpetrator and target

  2021cites this paper
• Immunocytometric Analysis of Oral Pemphigus vulgaris Patients after Treatment with Rituximab as Adjuvant

  2021cites this paper
• Engineered antigen-specific regulatory T cells for autoimmune skin conditions.

  2021cites this paper
• Pathogenic and protective roles of cytokines in pemphigus: A systematic review.

  2020cites this paper
• Investigating expression pattern of eight immune‐related genes in pemphigus patients compared with the healthy controls and after rituximab therapy: Potential roles of CTLA4 and FCGR3A genes expression in outcomes of rituximab therapy

  2020cites this paper
• Clinical and biological activity of rituximab in the treatment of pemphigus.

  2020cites this paper
• Novel Therapies for Pemphigus Vulgaris

  2020cites this paper
• Functional inhibition of regulatory CD4+CD25+T cells in peripheral blood of patients with pemphigus vulgaris

  2020cites this paper
• Increased expression of miR‐338‐3p impairs Treg‐mediated immunosuppression in pemphigus vulgaris by targeting RUNX1

  2020cites this paper
• Regulatory T-cell therapy in Crohn’s disease: challenges and advances

  2020cites this paper
• Role of Regulatory Immune Cells and Molecules in Autoimmune Bullous Dermatoses

  2019cites this paper
• Skin Barrier and Autoimmunity—Mechanisms and Novel Therapeutic Approaches for Autoimmune Blistering Diseases of the Skin

  2019cites this paper
• From bench to bedside: evolving therapeutic targets in autoimmune blistering disease

  2019cites this paper
• Updates on diagnosis and management of autoimmune blistering diseases.

  2019cites this paper
• Biologic and Systemic Agents in Dermatology

  2018cites this paper
• Role of Intravenous Immunoglobulin in Dermatologic Disorders

  2018cites this paper
• Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: The next frontier.

  2018cites this paper
• Role of FOXP3 gene polymorphism in the susceptibility to Tunisian endemic Pemphigus Foliaceus.

  2017cites this paper
• Phenotypical analysis of ectoenzymes CD39/CD73 and adenosine receptor 2A in CD4+ CD25highFoxp3+ regulatory T‐cells in psoriasis

  2017cites this paper
• The possible role of interleukin-35 and its therapeutic potential in pemphigus.

  2017cites this paper
• Increased miR-424-5p expression in peripheral blood mononuclear cells from patients with pemphigus

  2017cites this paper
• Developing biomarkers for predicting clinical relapse in pemphigus patients treated with rituximab

  2017cites this paper
• Rituximab treatment in pemphigus vulgaris: effect on circulating Tregs

  2017cites this paper
• Assessment of the Effects of Rituximab Monotherapy on Different Subsets of Circulating T-Regulatory Cells and Clinical Disease Severity in Severe Pemphigus Vulgaris

  2016cites this paper
• The dual nature of retinoic acid in pemphigus and its therapeutic potential: Special focus on all-trans Retinoic Acid.

  2016cites this paper
• Increased Frequency of T Follicular Helper Cells and Elevated Interleukin-27 Plasma Levels in Patients with Pemphigus

  2016cites this paper
• Induction of T regulatory cells by the superagonistic anti‐CD28 antibody D665 leads to decreased pathogenic IgG autoantibodies against desmoglein 3 in a HLA‐transgenic mouse model of pemphigus vulgaris

  2016cites this paper
• Impaired function of CD19+CD24hiCD38hi regulatory B cells in patients with pemphigus

  2015cites this paper
• Immune cellular regulation on autoantibody production in pemphigus

  2015cites this paper
• Clinical application of gancyclovir in the complex treatment of the different forms of true acantholytic pemphigus

  2015cites this paper
• Immunohistochemical analysis of FOXP3+ regulatory T cells in healthy human skin and autoimmune dermatoses

  2014cites this paper
• Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid

  2014cites this paper
• Flow cytometric analyses of circulating regulatory T cells in patients with dermatitis herpetiformis and other immune mediated dermatoses.

  2013cites this paper
• Both qualitative and quantitative genetic variation of MHC class II molecules may influence susceptibility to autoimmune diseases: the case of endemic pemphigus foliaceus.

  2013cites this paper
• Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris

  2013cites this paper
• Desmoglein 3, its pathogenecity and a possibility for therapeutic target in pemphigus vulgaris

  2013cites this paper
• Análise de expressão de MicroRNA candidatos à regulação da resposta imune adaptativa em Pênfigo Foliáceo

  2013cites this paper
• The imbalance of Th17 and regulatory T cells in pemphigus patients.

  2013cites this paper
• Circulating CD4+ CD25brightFOXP3+ regulatory T-cells are significantly reduced in bullous pemphigoid patients

  2012cites this paper
• Regulation generation: the suppressive functions of human regulatory T cells.

  2012cites this paper
• Cytokine networks in Pemphigus vulgaris: An integrated viewpoint

  2012cites this paper
• Pemphigus pathogenesis: problems and prospects

  2012cites this paper
• Methods for revealing therapeutic targets in case of true acantholytic pemphigus

  2012cites this paper
• Constructing immunoprofiles to deconstruct disease complexity in pemphigus

  2012cites this paper
• Epigenetics, autoimmunity and hematologic malignancies: a comprehensive review.

  2012cites this paper
• Antigen-independent development of Foxp3+ regulatory T cells suppressing autoantibody production in experimental pemphigus vulgaris.

  2011cites this paper
• Perfil imunoistoquímico de linfócitos T regulatórios no pênfigo foliáceo endêmIco através da expressão do marcador FOXP3

  2011cites this paper
• Pemphigus autoimmunity: Hypotheses and realities

  2011cites this paper
• CANINE T-REGULATORY CELLS IN AGING AND CANCER: QUANTIFYING A UNIQUE T CELL SUBSET

  2010cites this paper
• Canine T-regulatory cells in aging and cancer : quantifying a unique T cell subset

  2010cites this paper
• Possible Implication of Local Immune Response in Darier's Disease: An Immunohistochemical Characterization of Lesional Inflammatory Infiltrate

  2010cites this paper
• Immune dysregulation of pemphigus in humans and mice

  2010cites this paper
• Evaluation of Circulating CD4 + CD25 high Foxp3 + T-Lymphocytes in Active Non-Segmental Vitiligo

  2009cites this paper
• Lesional Th17 cells in pemphigus vulgaris and pemphigus foliaceus.

  2009cites this paper
• Advances in pemphigus and its endemic pemphigus foliaceus (Fogo Selvagem) phenotype: a paradigm of human autoimmunity.

  2008cites this paper
• Transcription factors in autoimmune diseases.

  2008cites this paper
• THE INFLUENCE OF TREATMENT OF PEMPHIGUS VULGARISON THE SERUM LEVEL OF CYTOKINES

  2008cites this paper
• A Case of Pemphigus Vulgaris with Serum Autoantibodies Binding Blood Cell Antigen(s) on Immunofluorescence: A Case Report

  2007cites this paper
• Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid

  year unknowncites this paper